Stock Events

Stock Events

Pulse Biosciences 

$26
8
+$0.11+0.42% Tuesday 20:00

Statistics

Day High
26.51
Day Low
25.63
52W High
27.1
52W Low
12.66
Volume
197,177
Avg. Volume
-
Mkt Cap
1.77B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12AugExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.31
-0.26
-0.21
-0.16
Expected EPS
-0.275
Actual EPS
N/A

Financials

-20,794.57%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
700,000Revenue
-145.56MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PLSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap85.88B
Boston Scientific Corporation offers a wide range of medical devices that compete in the cardiovascular and neuromodulation markets, overlapping with Pulse Biosciences' therapeutic areas.
Medtronic
MDT
Mkt Cap100.91B
Medtronic is a global leader in medical technology, services, and solutions, competing across several of Pulse Biosciences' key areas, including cardiac and vascular therapies.
Intuitive Surgical
ISRG
Mkt Cap155.16B
Intuitive Surgical, known for its da Vinci surgical systems, competes with Pulse Biosciences in the field of minimally invasive surgery, albeit through different technological approaches.
Stryker
SYK
Mkt Cap121.33B
Stryker is a medical technologies firm that competes with Pulse Biosciences in the development of surgical and neurotechnology products.
Zimmer Biomet
ZBH
Mkt Cap16.54B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, offering products that can be seen as alternatives to Pulse Biosciences' treatments.
Edwards Lifesciences
EW
Mkt Cap49.39B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing with Pulse Biosciences in the broader field of medical devices for cardiovascular health.
Baxter International
BAX
Mkt Cap9.91B
Baxter International Inc. provides a broad portfolio of renal and hospital products, including bio-surgery products that compete with Pulse Biosciences' offerings in the surgical market.

About

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Show more...
CEO
Mr. Paul Arthur LaViolette M.B.A.
Employees
75
Country
United States
ISIN
US74587B1017

Listings

MU
DE
6L8.MU
STU
DE
6L8.STU
F
DE
6L8.F
XNAS
US
PLSE

0 Comments

Share your thoughts

FAQ

What is Pulse Biosciences stock price today?▼
The current price of PLSE is $26 USD — it has increased by +0.42% in the past 24 hours. Watch Pulse Biosciences stock price performance more closely on the chart.
What is Pulse Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pulse Biosciences stocks are traded under the ticker PLSE.
Is Pulse Biosciences stock price growing?▼
PLSE stock has fallen by -0.34% compared to the previous week, the month change is a +14.79% rise, over the last year Pulse Biosciences has showed a +53.57% increase.
What is Pulse Biosciences market cap?▼
Today Pulse Biosciences has the market capitalization of 1.77B
When is the next Pulse Biosciences earnings date?▼
Pulse Biosciences is going to release the next earnings report on August 12, 2026.
What were Pulse Biosciences earnings last quarter?▼
PLSE earnings for the last quarter are -0.24 USD per share, whereas the estimation was -0.27 USD resulting in a +11.8% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pulse Biosciences revenue for the last year?▼
Pulse Biosciences revenue for the last year amounts to 700,000 USD.
What is Pulse Biosciences net income for the last year?▼
PLSE net income for the last year is -145.56M USD.
How many employees does Pulse Biosciences have?▼
As of May 27, 2026, the company has 75 employees.
In which sector is Pulse Biosciences located?▼
Pulse Biosciences operates in the Health & Wellness sector.
When did Pulse Biosciences complete a stock split?▼
Pulse Biosciences has not had any recent stock splits.
Where is Pulse Biosciences headquartered?▼
Pulse Biosciences is headquartered in Miami, United States.